Jarvis, Blair; Perry, Caroline M. - In: Disease Management and Health Outcomes 9 (2001) 4, pp. 215-234
According to the WHO, approximately 350 million people have chronic hepatitis B. Individuals with chronic hepatitis B have a highly variable and unpredictable clinical course and are at risk for developing cirrhosis and hepatocellular carcinoma. Lamivudine is the only oral antiviral agent...
